Associations between artificial sweeteners and cardiovascular disease, stroke, and diabetes: A Mendelian randomization study
American Journal of Preventive Cardiology · 2025-12 · 24 · 101325
DOI: 10.1016/j.ajpc.2025.101325 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2025-12. Verfasst von Jinming Fan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Cerebrovascular Disease, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Bioinformatics Institute.
Themen: Diabetes mellitus, Schlaganfall
Abstract (Originalsprache)
Background
Erythritol is a widely used artificial sweetener, yet its long-term impact on cardiometabolic health remains debated. This study aimed to investigate the genetic associations of erythritol with cardiovascular disease (CVD), stroke, and diabetes using a two-sample Mendelian randomization (TSMR) approach.
Methods
We utilized single-nucleotide polymorphisms (SNPs) associated with erythritol levels from genome-wide association studies (GWAS) as instrumental variables (IVs). The primary analysis employed the inverse-variance weighted (IVW) method. Robustness was assessed using multiple sensitivity analyses (including MR-Egger, weighted median, weighted multitude, and simple mode). Heterogeneity test, pleiotropy test, and sensitivity analysis were also conducted to further ensure the accuracy and stability of the research results.
Results
Erythritol showed positive associations with coronary heart disease (CHD) (OR = 1.0020, 95% CI: 1.0007-1.0034, P = 0.0034), myocardial infarction (MI) (OR = 1.0015, 95% CI: 1.0004-1.0026, P = 0.0090), and stroke (OR = 1.0463, 95% CI: 1.0010-1.0937, P = 0.0449) according to the IVW method. There was suggestive evidence of a positive association between erythritol and CHD, MI, and stroke. No significant causal association was observed between erythritol with heart failure (HF) and diabetes.
Conclusions
This TSMR study provides genetic evidence suggesting erythritol is associated with an increased risk of CHD, MI, and stroke, but not with HF or diabetes. Our findings could further clarify the effect of erythritol on CVD, stroke and diabetes, and thus be more beneficial in reducing the risk of disease. Clinical trial number: not applicable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Cerebrovascular Disease, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, China.
- Center of Interventional Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, China.
- Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China.
- Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China.
- Department of Nursing, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, China.
Förderung
- European Bioinformatics Institute
Zitieren
APA
Fan, J., Hu, Y., Zhang, J., Chen, J., Yuan, Y., & Yu, B. (2025). Associations between artificial sweeteners and cardiovascular disease, stroke, and diabetes: A Mendelian randomization study. American Journal of Preventive Cardiology, 24, 101325. https://doi.org/10.1016/j.ajpc.2025.101325
Vancouver
Fan J, Hu Y, Zhang J, Chen J, Yuan Y, Yu B. Associations between artificial sweeteners and cardiovascular disease, stroke, and diabetes: A Mendelian randomization study. American Journal of Preventive Cardiology. 2025;24:101325. doi:10.1016/j.ajpc.2025.101325
BibTeX
@article{Fan2025,
author = {Fan, Jinming and Hu, Yifei and Zhang, Junzhu and Chen, Jiawen and Yuan, Yajun and Yu, Benshuai},
title = {Associations between artificial sweeteners and cardiovascular disease, stroke, and diabetes: A Mendelian randomization study},
journal = {American Journal of Preventive Cardiology},
year = {2025},
volume = {24},
pages = {101325},
doi = {10.1016/j.ajpc.2025.101325}
}
EUVIMED